Trials / Completed
CompletedNCT03312140
Examination of the Lipid Metabolism of the Liver After Choline Substitution in Cystic Fibrosis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- University Hospital Tuebingen · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Pilot study to investigate the effect of choline chloride in cystic fibrosis patients with liver steatosis by comparing their status before and after the intervention
Detailed description
Within this single arm pilot study patients with cystic fibrosis and liver steatosis receive choline chloride (2x0.5 gram three times a day) as a food supply for 88 days. D9-choline metabolism is measured before and after the intervention phase. Hypothesis of the study is, that supplying choline augments the secretion of phosphatidyl choline and lipoprotein (VLDL) from the liver and therefore results in a measurable reduction of the triglyceride storage of the liver.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Choline Chloride |
Timeline
- Start date
- 2014-11-06
- Primary completion
- 2016-04-24
- Completion
- 2017-02-08
- First posted
- 2017-10-17
- Last updated
- 2017-11-30
Source: ClinicalTrials.gov record NCT03312140. Inclusion in this directory is not an endorsement.